Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Literature data-based de novo candidates for drug repurposing.

ABSTRACT:

SUBMITTER: Liang X

PROVIDER: S-EPMC12317455 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Literature data-based de novo candidates for drug repurposing.

Liang Xianglong X Jiang Xin X Ma Yifang Y

BMC bioinformatics 20250801 1

BACKGROUND: Drug repurposing offers a promising strategy for drug discovery. Drug repurposing involves identifying new therapeutic indications for existing, marketed drugs, thereby reducing the risks, costs, and time typically required for drug development. Various methods exist for drug repurposing, including high-throughput screening of drug compound libraries, computation in silico approaches, literature-based methods, etc. Currently, numerous methods utilize literature for data mining in dru ...[more]

PMID: 40750838

Similar Datasets

Systematically Prioritizing Candidates in Genome-Based Drug Repurposing.

Project description: Not available

| S-EPMC6921094 | biostudies-literature

Framework for identifying drug repurposing candidates from observational healthcare data.

Project description: Not available

| S-EPMC7886555 | biostudies-literature

Drug repurposing for the treatment of HIV-Associated Neurocognitive Disorder by AI-based literature mining

Project description:HIV-1 Associated Neurocognitive Disorder (HAND) is a common and clinically detrimental complication of HIV infection. Viral proteins including Tat, released from infected cells, cause neuronal toxicity. Substance abuse in HIV-infected patients greatly exacerbates the severity of neuronal damage. To repurpose small molecule inhibitors for anti-HAND therapy, we employed MOLIERE, an AI-based literature mining system that we developed. All human genes were analyzed and prioritized by MOLIERE to find previously unknown targets connected to HAND. The list was narrowed to those with known small molecule inhibitors developed for other applications and lacking systemic toxicity in animal models. We tested the activity of small molecules targeted against the proteins of five prioritized genes to protect against the combined neurotoxicity of HIV-Tat and cocaine in primary neuronal cultures. Four prevented Tat and cocaine toxicity. The compounds are: the FDA approved drugs Amlexanox and Tazemetostat (EPZ-6438), Itaconate and Senicapoc. Despite the disparate molecular targets of these drugs, analysis revealed a common mechanism of neuroprotection; namely that modulation of astrocyte and microglia status prevents the toxicity of Tat and cocaine.

2024-10-30 | GSE269380 | GEO

Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis.

Project description: Not available

| S-EPMC8879451 | biostudies-literature

Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data.

Project description: Not available

| S-EPMC6584997 | biostudies-literature

Machine Learning Identifies Candidates for Drug Repurposing in Alzheimer's Disease

Project description:Clinical trials of novel therapeutics for Alzheimer's Disease (AD) have consumed a large amount of time and resources with largely negative results. Repurposing drugs already approved by the Food and Drug Administration (FDA) for another indication is a more rapid and less expensive option. In this study, we profile 80 FDA-approved and clinically tested drugs in neural cell cultures, with the goal of producing a ranked list of possible repurposing candidates.

2021-01-14 | GSE164788 | GEO

Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension.

Project description: Not available

| S-EPMC8748496 | biostudies-literature

Uncovering drug repurposing candidates for head and neck cancers: insights from systematic pharmacogenomics data analysis.

Project description: Not available

| S-EPMC8671460 | biostudies-literature

Repurposing of Drug Candidates for Treatment of Skin Cancer.

Project description: Not available

| S-EPMC7821387 | biostudies-literature

A flexible data-free framework for structure-based <i>de novo</i> drug design with reinforcement learning.

Project description: Not available